HRP20080127T3 - Novi derivati 4-benziliden-piperidina - Google Patents

Novi derivati 4-benziliden-piperidina

Info

Publication number: HRP20080127T3
Authority: HR; Croatia
Prior art keywords: optionally substituted; halogen atom; oxo; thioxo; amino
Prior art date: 2004-07-29

Application number

HR20080127T

Other languages

English (en)

Croatian (hr)

Inventor

Borza Istv�n

Horv�th Csilla

Farkas S�ndor

Gyerty�n Istv�n

Nagy J�zsef

Kolok S�ndor

Galg�czy Korn�l

S�ghy Katalin

Original Assignee

Richter Gedeon Vegy�szeti Gy�r RT

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-29

Filing date

2005-07-21

Publication date

2008-04-30

2005-07-21 Application filed by Richter Gedeon Vegy�szeti Gy�r RT filed Critical Richter Gedeon Vegy�szeti Gy�r RT

2008-04-30 Publication of HRP20080127T3 publication Critical patent/HRP20080127T3/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Virology (AREA)
Diabetes (AREA)
Psychology (AREA)
AIDS & HIV (AREA)
Oncology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HR20080127T 2004-07-29 2005-07-21 Novi derivati 4-benziliden-piperidina HRP20080127T3 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0401522A HUP0401522A2 (en)	2004-07-29	2004-07-29	New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
PCT/HU2005/000077 WO2006010964A1 (en)	2004-07-29	2005-07-21	New 4-benzylidene-piperidin derivatives

Publications (1)

Publication Number	Publication Date
HRP20080127T3 true HRP20080127T3 (hr)	2008-04-30

Family

ID=89985407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20080127T HRP20080127T3 (hr)	2004-07-29	2005-07-21	Novi derivati 4-benziliden-piperidina

Country Status (31)

Country	Link
US (1)	US8008326B2 (de)
EP (1)	EP1773810B1 (de)
JP (1)	JP4814880B2 (de)
KR (1)	KR20070058428A (de)
CN (1)	CN1989128A (de)
AP (1)	AP2074A (de)
AT (1)	ATE387440T1 (de)
AU (1)	AU2005266159B2 (de)
BR (1)	BRPI0513902A (de)
CA (1)	CA2574148A1 (de)
CY (1)	CY1107368T1 (de)
DE (1)	DE602005005064T2 (de)
DK (1)	DK1773810T3 (de)
EA (1)	EA011241B1 (de)
ES (1)	ES2302214T3 (de)
GE (1)	GEP20084492B (de)
HR (1)	HRP20080127T3 (de)
HU (1)	HUP0401522A2 (de)
IL (1)	IL179484A0 (de)
MA (1)	MA28816B1 (de)
MX (1)	MX2007001055A (de)
NO (1)	NO20071108L (de)
NZ (1)	NZ552137A (de)
PL (1)	PL1773810T3 (de)
PT (1)	PT1773810E (de)
RS (1)	RS50573B (de)
SI (1)	SI1773810T1 (de)
TN (1)	TNSN07018A1 (de)
UA (1)	UA87862C2 (de)
WO (1)	WO2006010964A1 (de)
ZA (1)	ZA200700320B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007099828A1 (ja)	2006-02-23	2007-09-07	Shionogi & Co., Ltd.	環式基で置換された含窒素複素環誘導体
CN101426381A (zh) *	2006-04-21	2009-05-06	西诺米克斯公司	含有高效鲜味调料的可食用组合物及其制备方法
DE602007007759D1 (de) *	2006-06-08	2010-08-26	Bristol Myers Squibb Co	Alken-piperidin-derivate als antivirale wirkstoffe
JP2011527689A (ja) *	2008-07-08	2011-11-04	リヒターゲデオンエヌワイアールティー．	２−［４−（４−フルオロ−ベンジル）−ピペリジン−１−イル］−２−オキソ−ｎ−（２−オキソ−２，３−ジヒドロ−ベンゾオキサゾール−６−イル）−アセトアミドの結晶形態
AU2011216950A1 (en)	2010-02-16	2012-08-23	Pfizer Inc.	(R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors
WO2012033069A1 (ja)	2010-09-07	2012-03-15	大鵬薬品工業株式会社	プロスタグランジンd合成酵素を阻害するピペリジン化合物
US20120322824A1 (en) *	2011-01-04	2012-12-20	Surratt Christopher K	Cocaine Antagonist/Antidepressant Pharmaceutical Preparations
ES2627541T3 (es)	2012-04-20	2017-07-28	Ucb Pharma, S.A.	Métodos para tratar la enfermedad de Parkinson
BR112017003658B1 (pt)	2014-08-28	2022-12-06	Asceneuron Sa	Composto, mistura, método para inibição de uma glicosidase, e, composição farmacêutica
US10913733B2 (en)	2015-12-18	2021-02-09	Alectos Therapeutics Inc.	Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof
EP3585783A2 (de)	2016-02-25	2020-01-01	Asceneuron SA	Sulfoximin-glycosidase-inhibitoren
AU2017222964B2 (en)	2016-02-25	2020-01-02	Asceneuron S. A.	Glycosidase inhibitors
EP3419976B1 (de)	2016-02-25	2021-04-07	Asceneuron SA	Säureadditionssalze von piperazinderivaten
US11612599B2 (en)	2016-02-25	2023-03-28	Asceneuron Sa	Glycosidase inhibitors
US9486444B1 (en)	2016-03-21	2016-11-08	King Saud University	Anti-cancer compound
EP3672959A1 (de)	2017-08-24	2020-07-01	Asceneuron SA	Lineare glycosidase-inhibitoren
WO2020039028A1 (en)	2018-08-22	2020-02-27	Asceneuron S. A.	Tetrahydro-benzoazepine glycosidase inhibitors
US11731972B2 (en)	2018-08-22	2023-08-22	Asceneuron Sa	Spiro compounds as glycosidase inhibitors
EP3841093B1 (de)	2018-08-22	2023-06-21	Asceneuron SA	Succinat- und fumarat-säureadditionssalze von piperazinderivaten zur verwendung als glycosidase inhibitoren
US12016852B2 (en)	2018-08-22	2024-06-25	Asceneuron Sa	Pyrrolidine glycosidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA9610738B (en) *	1995-12-22	1997-06-24	Warner Lambert Co	Subtype selective nmda receptor ligands and the use thereof
TW498067B (en) *	1996-07-19	2002-08-11	Hoffmann La Roche	4-hydroxy-piperidine derivatives
CA2220649C (en)	1996-12-03	2007-02-13	F. Hoffmann-La Roche Ag	4-hydroxy-piperidine derivatives
ATE408611T1 (de) *	2001-07-24	2008-10-15	Richter Gedeon Nyrt	Piperidine als nmda-rezeptorantagonisten

2004
- 2004-07-29 HU HU0401522A patent/HUP0401522A2/hu unknown
2005
- 2005-07-21 PL PL05763197T patent/PL1773810T3/pl unknown
- 2005-07-21 MX MX2007001055A patent/MX2007001055A/es active IP Right Grant
- 2005-07-21 DE DE602005005064T patent/DE602005005064T2/de not_active Expired - Lifetime
- 2005-07-21 AU AU2005266159A patent/AU2005266159B2/en not_active Ceased
- 2005-07-21 SI SI200530213T patent/SI1773810T1/sl unknown
- 2005-07-21 HR HR20080127T patent/HRP20080127T3/xx unknown
- 2005-07-21 EA EA200700367A patent/EA011241B1/ru not_active IP Right Cessation
- 2005-07-21 US US11/658,789 patent/US8008326B2/en not_active Expired - Fee Related
- 2005-07-21 EP EP05763197A patent/EP1773810B1/de not_active Expired - Lifetime
- 2005-07-21 WO PCT/HU2005/000077 patent/WO2006010964A1/en not_active Ceased
- 2005-07-21 ES ES05763197T patent/ES2302214T3/es not_active Expired - Lifetime
- 2005-07-21 RS RSP-2008/0123A patent/RS50573B/sr unknown
- 2005-07-21 NZ NZ552137A patent/NZ552137A/xx not_active IP Right Cessation
- 2005-07-21 CN CNA2005800243746A patent/CN1989128A/zh active Pending
- 2005-07-21 PT PT05763197T patent/PT1773810E/pt unknown
- 2005-07-21 CA CA002574148A patent/CA2574148A1/en not_active Abandoned
- 2005-07-21 BR BRPI0513902-3A patent/BRPI0513902A/pt not_active IP Right Cessation
- 2005-07-21 AT AT05763197T patent/ATE387440T1/de active
- 2005-07-21 DK DK05763197T patent/DK1773810T3/da active
- 2005-07-21 KR KR1020077000262A patent/KR20070058428A/ko not_active Ceased
- 2005-07-21 AP AP2006003839A patent/AP2074A/en active
- 2005-07-21 UA UAA200702171A patent/UA87862C2/ru unknown
- 2005-07-21 GE GEAP20059892A patent/GEP20084492B/en unknown
- 2005-07-21 JP JP2007523160A patent/JP4814880B2/ja not_active Expired - Fee Related
2006
- 2006-11-22 IL IL179484A patent/IL179484A0/en unknown
2007
- 2007-01-11 ZA ZA200700320A patent/ZA200700320B/en unknown
- 2007-01-17 TN TNP2007000018A patent/TNSN07018A1/en unknown
- 2007-02-22 MA MA29703A patent/MA28816B1/fr unknown
- 2007-02-27 NO NO20071108A patent/NO20071108L/no not_active Application Discontinuation
2008
- 2008-03-27 CY CY20081100349T patent/CY1107368T1/el unknown

Also Published As

Publication number	Publication date
AP2006003839A0 (en)	2006-12-31
HK1105966A1 (en)	2008-02-29
DK1773810T3 (da)	2008-06-23
AU2005266159B2 (en)	2011-09-29
WO2006010964A1 (en)	2006-02-02
JP2008508247A (ja)	2008-03-21
TNSN07018A1 (en)	2008-06-02
AP2074A (en)	2009-12-14
NZ552137A (en)	2009-08-28
KR20070058428A (ko)	2007-06-08
DE602005005064D1 (de)	2008-04-10
EP1773810A1 (de)	2007-04-18
AU2005266159A1 (en)	2006-02-02
US8008326B2 (en)	2011-08-30
IL179484A0 (en)	2007-05-15
NO20071108L (no)	2007-02-27
PT1773810E (pt)	2008-04-09
US20080312222A1 (en)	2008-12-18
ZA200700320B (en)	2008-05-28
EA011241B1 (ru)	2009-02-27
GEP20084492B (en)	2008-09-25
EP1773810B1 (de)	2008-02-27
CN1989128A (zh)	2007-06-27
MX2007001055A (es)	2007-04-16
BRPI0513902A (pt)	2008-05-20
HUP0401522A2 (en)	2006-04-28
MA28816B1 (fr)	2007-08-01
DE602005005064T2 (de)	2009-02-26
CA2574148A1 (en)	2006-02-02
PL1773810T3 (pl)	2008-07-31
HU0401522D0 (en)	2004-09-28
CY1107368T1 (el)	2012-12-19
RS50573B (sr)	2010-05-07
JP4814880B2 (ja)	2011-11-16
SI1773810T1 (sl)	2008-06-30
UA87862C2 (en)	2009-08-25
EA200700367A1 (ru)	2007-06-29
ATE387440T1 (de)	2008-03-15
ES2302214T3 (es)	2008-07-01

Publication	Publication Date	Title
CO5560570A2 (es)	2005-09-30	Nuevos compuestos de amida de acido carboxilico y procedimiento para la sintesis de los mismos
TNSN07018A1 (en)	2008-06-02	New 4-benzylidene-piperidin derivatives
CO6290646A2 (es)	2011-06-20	Derivados de oxadiazol activos sobre fosfato de esfingosina-1
ES2571028T3 (es)	2016-05-23	Compuestos inhibidores de fosfoinositida 3-cinasa y métodos de uso
HRP20040429B1 (hr)	2007-10-31	Derivati sulfonamida, njihova priprema i upotrebakao lijekova
PE20060525A1 (es)	2006-07-13	Compuestos heterociclicos como inhibidores de cetp
AR069961A1 (es)	2010-03-03	Derivados de (aza)indol sustituidos en la posicion 5 utiles en el tratamiento de la inflamacion y el dolor, composiciones farmaceuticas que los comprenden, proceso de preparacion de los mismos y compuestos intermediarios.
AR043195A1 (es)	2005-07-20	Inhibidores no nucleosidos de la transcriptasa inversa derivados de pirazol
EA201071113A1 (ru)	2011-04-29	ПОЛИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 2-ГЕТЕРОАРИЛ-6-ФЕНИЛИМИДАЗО[1,2-α] ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
WO2008088692A3 (en)	2008-09-18	Spirochromanon derivatives
EP1535910A4 (de)	2007-03-14	Chinolinderivate und chinazolinderivate, die die autophosphorilierung des macrophage colony stimulating factor receptors inhibieren
PE20081447A1 (es)	2008-11-20	Compuestos y composiciones como inhibidores de la proteina cinasa
NO20005881D0 (no)	2000-11-21	Heterocykliske forbindelser og metoder for å behandle kardialsvikt og andre sykdommer
NZ763248A (en)	2023-06-30	Cap-dependent endonuclease inhibitors
PE20081378A1 (es)	2008-11-12	Derivados de 1,2,4-triazol como moduladores de mglur5
PE20020352A1 (es)	2002-05-11	Imidazoles sustituidos como inhibidores carboxipeptidasa
AR051767A1 (es)	2007-02-07	Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion
ATE554147T1 (de)	2012-05-15	Neue organische fluoreszierende sulfonylharnstoff-benzoxazinon-pigmente
AR008372A1 (es)	2000-01-19	Compuestos de benzoxazinona que son antagonistas de receptores de dopamina 4, metodo para tratar psicosis y ezquizofrenia utilizando dichos compuestos ycomposicion que los contiene
HRP20030610B1 (en)	2006-02-28	Process for the preparation of mesylates of piperazine derivatives
PE20071324A1 (es)	2008-03-05	Metodos de usar derivados de 3-piridilo como pesticidas
NO20071110L (no)	2007-02-27	Nye benzoylureaderivater
DE60107056D1 (de)	2004-12-16	Benzoxazolderivate als tnf und pde iv inhibitoren
EA200801536A1 (ru)	2008-12-30	Новые тиенопирсульфоновые производные
AR074915A1 (es)	2011-02-23	Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, composiciones farmaceuticas que los comprenden y uso de los mismos para el tratamiento de trastornos del aparato cardiovascular, glaucoma y otras patologias.